van Rosmalen J - Search Results

1

Incorporating historical controls in clinical trials with longitudinal outcomes using the modified power prior.

Qi H, Rizopoulos D, Lesaffre E, van Rosmalen J. Qi H, et al. Among authors: van rosmalen j. Pharm Stat. 2022 Sep;21(5):818-834. doi: 10.1002/pst.2195. Epub 2022 Feb 6. Pharm Stat. 2022. PMID: 35128780 Free PMC article.

2

Predicting hemoglobin levels in whole blood donors using transition models and mixed effects models.

Nasserinejad K, de Kort W, Baart M, Komárek A, van Rosmalen J, Lesaffre E. Nasserinejad K, et al. Among authors: van rosmalen j. BMC Med Res Methodol. 2013 May 2;13:62. doi: 10.1186/1471-2288-13-62. BMC Med Res Methodol. 2013. PMID: 23635008 Free PMC article.

3

Prevalence and determinants of declining versus stable hemoglobin levels in whole blood donors.

Nasserinejad K, van Rosmalen J, van den Hurk K, Baart M, Hoekstra T, Rizopoulos D, Lesaffre E, de Kort W. Nasserinejad K, et al. Among authors: van rosmalen j, van den hurk k. Transfusion. 2015 Aug;55(8):1955-63. doi: 10.1111/trf.13066. Epub 2015 Mar 10. Transfusion. 2015. PMID: 25753152

4

Personalized screening intervals for biomarkers using joint models for longitudinal and survival data.

Rizopoulos D, Taylor JM, Van Rosmalen J, Steyerberg EW, Takkenberg JJ. Rizopoulos D, et al. Among authors: van rosmalen j. Biostatistics. 2016 Jan;17(1):149-64. doi: 10.1093/biostatistics/kxv031. Epub 2015 Aug 28. Biostatistics. 2016. PMID: 26319700 Free PMC article.

5

Prediction of hemoglobin in blood donors using a latent class mixed-effects transition model.

Nasserinejad K, van Rosmalen J, de Kort W, Rizopoulos D, Lesaffre E. Nasserinejad K, et al. Among authors: van rosmalen j. Stat Med. 2016 Feb 20;35(4):581-94. doi: 10.1002/sim.6759. Epub 2015 Oct 14. Stat Med. 2016. PMID: 26467774

6

Comparison of Criteria for Choosing the Number of Classes in Bayesian Finite Mixture Models.

Nasserinejad K, van Rosmalen J, de Kort W, Lesaffre E. Nasserinejad K, et al. Among authors: van rosmalen j. PLoS One. 2017 Jan 12;12(1):e0168838. doi: 10.1371/journal.pone.0168838. eCollection 2017. PLoS One. 2017. PMID: 28081166 Free PMC article.

7

Including historical data in the analysis of clinical trials: Is it worth the effort?

van Rosmalen J, Dejardin D, van Norden Y, Löwenberg B, Lesaffre E. van Rosmalen J, et al. Among authors: van norden y. Stat Methods Med Res. 2018 Oct;27(10):3167-3182. doi: 10.1177/0962280217694506. Epub 2017 Feb 21. Stat Methods Med Res. 2018. PMID: 28322129 Free PMC article.

8

Use of a historical control group in a noninferiority trial assessing a new antibacterial treatment: A case study and discussion of practical implementation aspects.

Dejardin D, Delmar P, Warne C, Patel K, van Rosmalen J, Lesaffre E. Dejardin D, et al. Among authors: van rosmalen j. Pharm Stat. 2018 Mar;17(2):169-181. doi: 10.1002/pst.1843. Epub 2017 Dec 28. Pharm Stat. 2018. PMID: 29282862

9

Modified power prior with multiple historical trials for binary endpoints.

Banbeta A, van Rosmalen J, Dejardin D, Lesaffre E. Banbeta A, et al. Among authors: van rosmalen j. Stat Med. 2019 Mar 30;38(7):1147-1169. doi: 10.1002/sim.8019. Epub 2018 Oct 25. Stat Med. 2019. PMID: 30360016

10

Summarising salient information on historical controls: A structured assessment of validity and comparability across studies.

Hatswell A, Freemantle N, Baio G, Lesaffre E, van Rosmalen J. Hatswell A, et al. Among authors: van rosmalen j. Clin Trials. 2020 Dec;17(6):607-616. doi: 10.1177/1740774520944855. Epub 2020 Sep 21. Clin Trials. 2020. PMID: 32957804 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

269 results

Search Page

Filters